Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-06-16

Natural antimony resistance in leishmania donovani: a fundamental study to guide future epidemiological strategies

Objectif

Control of leishmaniasis is being challenged by the emergence of natural resistance against the first line treatment - pentavalent antimonials (SbV). Monitoring and prevention of the spreading of drug resistance is now a priority for the control of leishmaniasis.

In order to design and develop the required epidemiological tools, it is essential to understand the mechanism of natural SbV resistance and to gain insights into the dynamics of the emergence and/or spreading of drug resistance.

Within this context a multidisciplinary fundamental study is required to gain a comprehensive understanding of the natural SbV-resistance phenotype, including molecular basis, biochemical profile, and effect on parasite survival.

Champ scientifique (EuroSciVoc)

Mots‑clés

Thème(s)

Appel à propositions

FP6-2005-MOBILITY-5
Voir d’autres projets de cet appel

Régime de financement

EIF - Marie Curie actions-Intra-European Fellowships

Coordinateur

UNIVERSITY OF GLASGOW
Contribution de l’UE
Aucune donnée
Coût total
Aucune donnée